6.2.2.5 Guidelines for the treatment of intermediate-risk disease*,
Recommendations  Strength rating,
Radical prostatectomy (RP),
Offer RP to patients with cN0 disease as part of multi-modal therapy.   Weak,
Radiotherapeutic treatment,
"Offer IMRT/VMAT plus IGRT to the prostate in combination with long-term ADT and   2 years of abiraterone to cN0M0 patients with > 2 high-risk factors (cT3-4, Gleason   > 8 or PSA > 40 ng/mL).",Strong
Offer IMRT/VMAT plus IGRT to the prostate plus pelvis in combination with    long-term ADT and 2 years of abiraterone to cN1M0 patients.,Strong
Offer patients with cN1 disease a local treatment (either RP or IMRT/VMAT plus   IGRT) plus long-term ADT.,Strong
